Maharashtra FDA Chief Urges Review of Medical Device Pricing Amid High Markups
Maharashtra FDA Commissioner Tukaram Mundhe has highlighted significant markups on medical devices and hospital consumables, with some items priced up to 2,841% above procurement costs. A state survey revealed wide gaps between trade prices and maximum retail prices (MRPs) for products like IV sets, syringes, and catheters. Mundhe has urged the Department of Pharmaceuticals and the National Pharmaceutical Pricing Authority to review pricing rules, cap trade margins, and consider structured price monitoring to ensure affordability and transparency in medical device pricing.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 52%, Right 48%). Overall sentiment is neutral (50/100). Lens Score 62/100.
Outlets measured: businessstandard, moneycontrol, mint. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
All 2 outlets scored close to centre on political lean. The real divergence here is in emphasis, not lean — compare the headlines below to see how each outlet chose to frame the same facts.
Sentiment was consistent across outlets (48–70/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
mint broke this story on 15 Sept, 12:20 am. Other outlets followed.